Stock Price
41.52
Daily Change
-0.14 -0.34%
Monthly
20.07%
Yearly
69.61%
Q2 Forecast
40.52

Xoma reported $2.52M in EBITDA for its fiscal quarter ending in June of 2024.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Agenus USD -10.11M 19.02M Mar/2025
Agios Pharmaceuticals USD -120.31M 4.82M Dec/2025
Ardelyx USD 6.02M 447K Dec/2025
aTyr Pharma USD 25.85M 52.43M Dec/2025
BioMarin Pharmaceutical USD 146.05M 170.22M Mar/2026
Celldex Therapeutics USD -86.34M 13.54M Dec/2025
Curis USD -12.3M 231K Sep/2023
Eli Lilly USD 12.14B 4.26B Dec/2025
Incyte USD 367.97M 46.53M Mar/2026
MacroGenics USD 21.95M 55.39M Sep/2025
Novartis USD 5.3B 530M Mar/2026
Novartis USD 5.84B 235M Sep/2025
Pfizer USD 5.99B 5.23B Mar/2026
Prothena USD -39.53M 12.25M Sep/2025
Regeneron Pharmaceuticals USD 1.2B 718.4M Dec/2025
Xoma USD 2.52M 7.98M Jun/2024